“…Of these 19 study populations, seven assessed the diagnostic performance of gargle in populations with suspected infection [ 28 , 49 , 50 , 54 , 55 , 57 , 59 ], and 12 assessed the use of gargle for monitoring viral shedding in populations already confirmed to have SARS-CoV-2 infections, either as hospital inpatients or after being discharged ( table 1 ) [ 29 , 35 , 36 , 46 – 48 , 51 – 53 , 56 , 58 , 59 ]. Regarding the study location, there were five studies from Canada [ 28 , 47 , 50 , 52 , 57 ], six from Germany [ 36 , 48 , 49 , 51 , 54 , 56 ] and with the rest (seven) from Finland [ 29 ], Turkey [ 55 ], China [ 46 ], Korea [ 58 ], Indonesia [ 59 ], Israel [ 53 ] and India [ 35 ]. These studies spanned from 23 March 2020 to 19 July 2021, covering the period of different prevailing SARS-CoV-2 variants, from the ancestral strain, alpha variant, to its delta variant.…”